These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33759020)

  • 1. Hemoglobinuria for the early identification of STEC-HUS in high-risk children: data from the ItalKid-HUS Network.
    Capone V; Mancuso MC; Tamburini G; Montini G; Ardissino G
    Eur J Pediatr; 2021 Sep; 180(9):2791-2795. PubMed ID: 33759020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G; Vignati C; Masia C; Capone V; Colombo R; Tel F; Daprai L; Testa S; Dodaro A; Paglialonga F; Luini M; Brigotti M; Picicco D; Baldioli C; Pagani F; Ceruti R; Tommasi P; Possenti I; Cresseri D; Consonni D; Montini G; Arghittu M;
    J Pediatr; 2021 Oct; 237():34-40.e1. PubMed ID: 34197890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G
    Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy.
    Loconsole D; Giordano M; Laforgia N; Torres D; Santangelo L; Carbone V; Parisi A; Quarto M; Scavia G; Chironna M;
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):539-547. PubMed ID: 31776873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI;
    Trials; 2023 May; 24(1):359. PubMed ID: 37245030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA; Zhang C; Bard JE; Yergeau D; Halasa N; Gómez-Duarte OG
    BMC Genomics; 2020 Aug; 21(1):564. PubMed ID: 32807093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family Clusters of Shiga Toxin-producing Escherichia coli Infection: An Overlooked Source of Transmission. Data From the ItalKid-Hus Network.
    Luini MV; Colombo R; Dodaro A; Vignati C; Masia C; Arghittu M; Daprai L; Maisano AM; Vezzoli F; Bianchini V; Spelta C; Castiglioni B; Bertasi B; Ardissino G
    Pediatr Infect Dis J; 2021 Jan; 40(1):1-5. PubMed ID: 32898091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Shiga Toxin-Producing
    Loconsole D; Giordano M; Centrone F; Accogli M; Casulli D; De Robertis AL; Morea A; Quarto M; Parisi A; Scavia G; Chironna M; On Behalf Of The Bloody Diarrhea Apulia Working Group
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal Phase of Hemolytic Uremic Syndrome Related to Shiga Toxin-Producing Escherichia coli: The Wasted Time.
    Balestracci A; Meni Battaglia L; Toledo I; Martin SM; Alvarado C
    Pediatr Emerg Care; 2021 Oct; 37(10):e625-e630. PubMed ID: 31290797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina.
    Rivas M; Pichel M; Colonna M; Casanello AL; Alconcher LF; Galavotti J; Principi I; Araujo SP; Ramírez FB; González G; Pianciola LA; Mazzeo M; Suarez Á; Oderiz S; Ghezzi LFR; Arrigo DJ; Paladini JH; Baroni MR; Pérez S; Tamborini A; Chinen I; Miliwebsky ES; Goldbaum F; Muñoz L; Spatz L; Sanguineti S; ;
    Rev Argent Microbiol; 2023; 55(4):345-354. PubMed ID: 37301652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin producing
    Falup-Pecurariu O; Lixandru RI; Cojocaru E; Csutak K; Monescu V; Muhsen K; Falup-Pecurariu C; Cohen D
    Gut Pathog; 2019; 11():46. PubMed ID: 31572497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Treatment for Shiga Toxin-Producing
    Liu Y; Thaker H; Wang C; Xu Z; Dong M
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.
    Guirro M; Piazza RM; de Souza RL; Guth BE
    BMC Infect Dis; 2014 Jun; 14():320. PubMed ID: 24919599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Minary K; Tanne C; Kwon T; Faudeux C; Clave S; Langevin L; Pietrement C; Enoch C; Parmentier C; Mariani-Kurkdjian P; Weill FX; Jones G; Djouadi N; Morin D; Fila M
    Arch Pediatr; 2022 Aug; 29(6):448-452. PubMed ID: 35662540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016.
    Chokoshvili O; Vepkhvadze N; Davitaia T; Tevzadze L; Tsertsvadze T
    Georgian Med News; 2018 Oct; (283):123-129. PubMed ID: 30516507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.